Neurotransmitters and neuropeptides in the developing human central nervous system

NeuroSignals

Volumn 8, Issue 3, 1999, Pages 149-159

  Yew, David T ^a   Chan, W Y ^a   Luo, C B ^b   Zheng, D R ^b   Yu, M C ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b JINAN UNIVERSITY   (China)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

CNS; Development; Human; Neuropeptides; Neurotransmitters

Indexed keywords

4 AMINOBUTYRIC ACID; ENKEPHALIN; NEUROPEPTIDE; NEUROTRANSMITTER; PEPTIDE; SUBSTANCE P;

CATECHOLAMINE NERVE CELL; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE; CHOLINERGIC NERVE CELL; EMBRYO DEVELOPMENT; FACIAL NERVE NUCLEUS; FIRST TRIMESTER PREGNANCY; HIPPOCAMPUS; HUMAN; INTERNEURON; INTERPEDUNCULAR NUCLEUS; MORPHOGENESIS; NERVE FIBER; ONTOGENY; PEPTIDERGIC NERVOUS SYSTEM; RETINA; REVIEW; SENSE ORGAN;

CENTRAL NERVOUS SYSTEM; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PREGNANCY;

EID: 0032907296     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014586     Document Type: Article

References (58)

1. McCaman RE, Hunt JM: Microdetermination of choline acetylase in nervous tissue. J Neurochem 1965; 12:253-259.
2. Ross CD, Smith JT, Godfrey DA: Regional distributions of choline acetyltransferase and acetylcholes-terase activities in layers of rat cerebellar vermis. J Histochem Cyto-chem 1983;31:927-937.
3. de Lacalle S, Hersh LB, Saper CB: Cholinergic innervation of the human cerebellum. J Comp Neurol 1993;328;364-376.
4. Yew DT, Luo CB, Shen WZ, Chow PH, Zheng DR, Yu MC: Tyrosine hydroxylase and dopamine p hydroxylase positive neurons and fibers in the developing human cerebellum - An immunohistochemical study. Neuroscience 1995;5:453-461.
5. Yew DT, Webb S, Lam ETK: Neurotransmitters and peptides in the developing human facial nucleus. Neurosci Lett 1996;206:65-68.
6. Jenny AB, Saper CB: Organization of the facial nucleus and corticofa-cial projection in the monkey: A reconsideration of the upper neuron facial palsy. Neurology 1987;37: 930-939.
7. Fuxe K, Li XM, Tanganelli S, Hed-lund P, O’Connor WT, Ferraro L, Ungerstedt U, Agnati LF: Receptor-receptor interactions and their relevance for receptor diversity. Focus on neuropeptide/dopamine interactions. Ann NY Acad Sci 1995;757: 365-376.
8. Taniwaki T, Schwartz JP: Somatostatin enhances neurofilament expression and neurite outgrowth in cultured rat cerebellar granule cells. Brain Res Dev Brain Res 1995;88: 109-116.
9. Luo CB, Yew DT, Zheng DR, Liu Y Q: Acetylcholinesterase-containing neurons, substance P and enkephalin fibers in the ventral horns of developing human embryos and fetuses. Neuroscience 1992;48:979-984.
10. Luo CB, Zheng DR, Guan YL, Shen WZ, Liu YG, Yew DT: Localization of acetylcholinesterase positive neurons and substance P and enkephalin positive fibers by histochemistry and immunohistochemistry in the sympathetic intermediate zone of the developing human spinal cord. Neuroscience 1990;39:97-102.
11. Taquet H, Javoy-Agid F, Mau-borgne A, Benoliel JJ, Agid Y, Legrand JC, Tramu G, Cesselin F, Ha-mon M: Biochemical mapping of cholecystokinin, substance P, [Me-t]enkephalin, [Leu]enkephalin and dynorphin A(1-8) like immunoreac-tivities in human cerebral cortex. Neuroscience 1988;27:871-883.
12. Sakamoto N, Takatsuji K, Shiosaka S, Tohyama M: Evidence for the existence of substance P like immuno-reactive neurons in the human cerebral cortex: An immunohistochemical analysis. Brain Res 1985;325: 322-324.
13. Ng TB, Yew DT: Changes in P-endorphin and Met-enkephalin levels in different regions of the human fetal brain from the fourteenth to the twenty-first week of gestation; in Blum T, Yew D (eds): Human Prenatal Brain Development. Berlin, Leonardo 1993; pp 71-80.
14. Tiu SC, Li WY, Luo CB, Yew DT: Habenulo-interpeduncular descending pathways and their relationship to enkephalin and somatostatin-im-munoreactive neurons in the interpeduncular nucleus of human fetuses. Neuroscience 1993;53:489-493.
15. Yew DT, Pang KM, Mok YC: Immunohistochemical and ultrastructural studies of the various nuclei of the trigeminal complex in the human newborn. Neuroscience 1991; 45:23-35.
16. Yew DT, Luo CB, Zheng DR, Guan YL, Tsang D, Stadlin A: Immunohistochemical localization of substance P, enkephalin & serotonin in the developing human retina. J Hirnforsch 1991;32:61-67.
17. Floren I, Hendrickson A: Indoleamine accumulating horizontal cells in this squirrel monkey retina. Invest Ophthalmol Vis Sci 1984;25:997-1006.
18. Brecha NC, Hendrickson A, Floren I, Karten HJ: Localization of substance P-like immunoreactivity within the monkey retina. Invest Ophthalmol Vis Sci 1982;23:147-153.
19. Brecha NC, Karten HJ, Laverack: Enkephalin containing amacrine cells in the avian retina: Immunohistochemical localization. Proc Natl Acad USA 1979;76:3010-3014.
20. Brecha NC, Karten HJ: Localization of biologically active peptides in the rat; in Morgan WW (ed): Retinal transmitters and modulators. Florida, CRC, 1985, vol I, pp 93-118.
21. Lam DM, Su YY, Watt CB: The self regulating synapse: A functional role for the coexistence of neuroactive substances. Brain Res Rev 1986; 396:249-257.
22. Pourcho RG, Goebel DJ: Co-localization of substance P and gamma-aminobutyric acid in amacrine cells of the cat retina. Brain Res 1988; 447:164-168.
23. Jen PYP, Li WWY, Yew DT: Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience 1994;60:727-735.
24. Yu MC, Cho E, Luo CB, Li WWY, Shen WZ, Yew DT: Immunohistochemical studies of GABA and par-valbumin in the developing human cerebellum. Neuroscience 1996;70: 267-276.
25. 2+ binding properties in the human cerebellar cortex: Distribution of parvalbumin and calbindin D-28 immunoreactivity. Anat Embryol 1992;185:163-167.
26. Schiffman S, Campistron G, Tugendhaft P, Brotchi J, Flament-Du-rand J, Geffard M, Vanderhaeghen JJ: Immunocytochemical detection of GABAergic nerve cells in the human temporal cortex using a direct gamma-aminobutyric acid antiserum. Brain Res 1988;442:270-278.
27. Ong WY, Garey LJ: Distribution of GABA and neuropeptides in the human cerebral cortex: A light and electron microscopic study. Anat Embryol 1991;183:397-413.
28. Yan XX, Zheng DS, Garey LJ: Prenatal development of GABA-immu-noreactive neurons in the human striate cortex. Brain Res Dev Brain Res 1992;65; 191-204.
29. Zheng D: Prenatal development of GABA containing neurons in the human fetal cortex; in Blum T, Yew D (eds): Human Prenatal Brain Development. Berlin, Leonardo, 1993, pp 149-185.
30. Morley JE, Flood JF: Neuropeptide Y and memory processing. Ann NY Acad Sci 1990;611:226-231.
31. Ruan Y, Chen Y: Development of catecholaminergic system in the human fetal brain; in Blum T, Yew D (eds): Human Prenatal Brain Development. Berlin, Leonardo 1993, pp 81-112.
32. Specht LA, Pickel VM, Joh TH, Reis DJ: Light microscopic immu-nocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J Comp Neurol 1981;199:255-276.
33. Di Porzio U, Zuddas A, Cosenza-Murphy DB, Barker JL: Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos. Int J Dev Neurosci 1990;8:523-532.
34. Parnavelas JG, Blue ME: The role of the noradrenergic system on the formation of synapses in the visual cortex of the rat. Brain Res 1982;255: 140-144.
35. Commissiong JW: Development of catecholaminergic nerves in the spinal cord of the rat. Brain Res 1983; 264:197-208.
36. Konig N, Wilkie MB, Lauder JM: Tyrosine hydroxylase and serotonin containing cells in embryonic rat rhombencephalon: A whole-mount immunocytochemical study. J Neurosci Res 1988;20:212-223.
37. Yew DT, Luo CB, Zheng DR, Guan YQ, Lin YP, Chen WZ: Development and localization of enkephalin and substance P in the nucleus of tractus solitarius in the medulla oblongata of human fetuses. Neuroscience 1990;34:491-498.
38. Yu MC, Luo CB, Long L, Yew DT: An immunohistochemical study of neuropeptide Y positive sites in the developing human hippocampal formation. Brain Res Dev Brain Res 1993;72:277-281.
39. Li WP, Chan WY, Lai HWL, Yew DT: Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 1997;8:75-82.
40. Yew DT, Li WP, Webb SE, Lai HWL, Zhang L: Neurotransmitters, peptides and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients. Expt Gerontol, in press.
41. Navarro HA, Seidler FJ, Baker FE, Dobbins SS, Lappi SE, Slotkin TA: Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter system. Evidence of cholinergic trophic influences in developing human brain. J Pharmacol Exp Ther 1989;362:894-900.
42. McDonal JW, Johnston MV: Excitatory amino acid neurotoxicity in the developing brain. NIDA Res Mon-ogr 1993;133:185-205.
43. Ma W, Barker JL: GABA, GAD, and GABA(A) receptor alpha4, beta1, and gamma1 subunits are expressed in the late embryonic and early postnatal neocortical germinal matrix and coincide with gliogene-sis. Microsc Res Tech 1998;40:398-407.
44. Festoff BW, Nelson PG, Brenneman DE: Prevention of activity dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. J Neurobiol 1996;30: 255-266.
45. Turlejski K: Evolutionary ancient roles of serotonin: Long-lasting regulation of activity and development. Acta Neurobiol Exp 1996;56:619-636.
46. Grace AA, Gerfen CR, Aston-Jones G: Catecholamines in the central nervous system. Overview. Adv Pharmacol 1998;42:655-670.
47. Feifel D, Reza TL, Robeck SL: Prodopamine effects of neurotensin on sensorimotor gating deficits. Peptides 1997;18:1457-1460.
48. Hartman DS, Civelli O: Molecular attributes of dopamine receptors: New potiential for antipsychotic drug development. Ann Med 1996; 28:211-219.
49. Turner EE, Fedtsova N, Heste DV: Cellular and molecular neuropathology of schizophrenia: New directions from developmental neurobiology. Schizophr Res 1997;27:169-180.
50. Thome J, Foley P, Riederer P: Neurotrophic factors and the maldevel-opmental hypnosis of schizophrenic psychoses (review). J Neural Transm 1998;105:85-100.
51. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995;52:829-836.
52. Woo TU, Whitehead RE, Melchitz-ky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998;95:5341-5346.
53. Sakai K, Maeda K, Chihara K, Ka-neda H: Increases in cortical neuropeptide Y and somatostatin concentrations following haloperiodol-de-pot treatment in rats. Neuropeptides 1995;29:157-161.
54. Bachus SE, Hyde TM, Herman MM, Egan MF, Kleinman JE: Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J Psychiatr Res 1997;31: 233-256.
55. Gabriel SM, Davidson M, Haroutu-nian V, Powchik P, Bierer LM, Pu-rohit DP, Perl DP, David KL: Neuropeptide deficits in schizophrenia vs. Alzheimer’s disease cerebral cortex. Biol Psychiatry 1996;39:82-91.
56. Carlsson A: Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychol-pharmacol 1995;3:21-28.
57. Schloesser R, Simkowitz P, Bartlett EJ, Wolkin A, Smith GS, Dewey SL, Brodie JD: The study of neurotransmitter interactions using positron emission tomography and functional coupling. Clin Neuropharmacol 1996;19:371-389.
58. Whitton PS: Glutamatergic control over brain dopamine release in vivo and in vitro. Neurosci Biobehav Rev 1997;21:481-488.